Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - mannitol, quantity: 40 mg - inhalation, powder for - excipient ingredients: gelatin - bronchitol is indicated for the treatment of cystic fibrosis (cf) in both paediatric and adult populations six years and above as either an add-on therapy to dornase alfa or in patients intolerant to, or inadequately responsive to dornase alfa.

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - mannitol, quantity: 0 mg - capsule, hard - excipient ingredients: gelatin - aridol is indicated for identifying bronchial hyperresponsiveness to assist in the diagnosis of asthma.

Malta - English - Medicines Authority

vioser s.a. taxiarches, 42100 trikala, greece - mannitol - solution for infusion - mannitol 20 g/100ml - blood substitutes and perfusion solutions

United States - English - NLM (National Library of Medicine)

clipper - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol injection 20% is indicated for use as an osmotic diuretic in canine species. mannitol is essentially inert metabolically. when given parenterally, it is freely filtered at the glomerulus which produces osmotic diuresis as more than 90% of the mannitol injected escapes reabsorption.

United States - English - NLM (National Library of Medicine)

mwi (vetone) - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol injection 20% is indicated for use as an osmotic diuretic in canine species. mannitol is essentially inert metabolically. when given parenterally, it is freely filtered at the glomerulus which produces osmotic diuresis as more than 90% of the mannitol injected escapes reabsorption.

United States - English - NLM (National Library of Medicine)

neogen corporation - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol injection 20% is indicated for use as an osmotic diuretic in canine species. mannitol is essentially inert metabolically. when given parenterally, it is freely filtered at the glomerulus which produces osmotic diuresis as more than 90% of the mannitol injected escapes reabsorption.

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mannitol - solution for infusion - mannitol 100 mg/ml - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mannitol - solution for infusion - mannitol 150 mg/ml - blood substitutes and perfusion solutions

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - mannitol - solution for infusion - 20 per cent

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

10%) infusion viaflo bags (baxter healthcare ltd - mannitol - infusion - 100mg/1ml